¸ð½Ã´Â±Û ÇÁ·Î±×·¥ ÃÊ·ÏÁ¢¼ö »çÀüµî·Ï ¹ßÇ¥ÀÚ ¾È³» ¼ö»óÀÚ ¾È³» Çà»çÀå¾È³» ¼÷¹Ú¾È³» Ȩ

ÀϹݿ¬Á¦ ¹ßÇ¥ À¯ÀÇ»çÇ×

ÀϹݿ¬Á¦ ¹ßÇ¥ÀÚ´Â ¹Ýµå½Ã ¹ßÇ¥ ½½¶óÀ̵å(ÆÄ¿öÆ÷ÀÎÆ®)¸¦ »çÀü¿¡ Á¦ÃâÇÏ¼Å¾ß ¹ßÇ¥°¡ °¡´ÉÇÕ´Ï´Ù.
½½¶óÀ̵带 ±âÇÑ ³»¿¡ Á¦ÃâÇÏÁö ¾ÊÀ» °æ¿ì¿¡´Â ¹ßÇ¥ºÒ°¡´ÉÀ¸·Î °£ÁÖÇÕ´Ï´Ù.
¹ßÇ¥ ½½¶óÀ̵å¼ö´Â 15¸Å À̳»·Î 1Àå ´ç 10ÁÙ À̳»·Î Á¦ÀÛÇϽô °ÍÀ» ±ÇÀåÇϸç, ÁöÁ¤µÈ ¹ßÇ¥½Ã°£(7ºÐ ¹ßÇ¥-3ºÐ ÁúÀÇÀÀ´ä) À» Á¤È®È÷ ÁöÄÑÁֽñ⠹ٶø´Ï´Ù.

1. ÆÄÀÏ Á¦Ã⸶°¨ÀÏ : 9¿ù 17ÀÏ (¸ñ)
2. ÆÄÀÏ ÇüÅ : ÆÄ¿öÆ÷ÀÎÆ®
3. Á¦Ãâ ¹æ¹ý : ppt1@ksog.org


±¸¿¬ - Àüü   /    ¸ðüžÆÀÇÇР  /    ºÎÀÎÁ¾¾çÇР  /    »ý½Ä³»ºÐºñÇР  /    ÀϹݺÎÀΰúÇÐ

[ ±¸¿¬ - ¸ðüžÆÀÇÇÐ ]

½Ã°£ ¹øÈ£ ¼º¸í ¼Ò¼Ó Á¦¸ñ
ÁÂÀå : ¹ÚÀ±±â(¿µ³²ÀÇ´ë)
13:00~13:40 OB1 ±è½Âö ºÎ»êÀÇ´ë Placenta bed¿¡¼­ÀÇ SDF¿Í visfatinÀÇ ¹ßÇöÀÌ ÀüÀÚ°£Áõ¿¡ ¹ÌÄ¡´Â È¿°ú
OB2 ¹èÁöÇý °æºÏÀÇ´ë Serum NT-proBNP level as a marker for cardiopulmonary function in preeclampsia
OB3 ÇãÇý¿ø ¿¬¼¼ÀÇ´ë C-reactive protein concentrations and differential distributions of leukocytes in Preeclampsia
OB4 ¹é¼öÁø ¿ï»êÀÇ´ë Factors predicting failure following selective pelvic arterial embolization for severe postpartum hemorrhage
ÁÂÀå : ÃÖ¿íȯ(ºÎ»êÀÇ´ë)
13:40~14:20 OB5 ±èº´Àç ¼­¿ïÀÇ´ë ÇÁ·ÎÅ׿À¹Í½º¸¦ ÀÌ¿ëÇÑ »êÀü ½ºÅ×·ÎÀ̵å Åõ¿© ÀüÈÄÀÇ ¾ç¼ö³» ´Ü¹é º¯È­ ºÐ¼®
OB6 °­Á¤¹è ÇѸ²ÀÇ´ë Self-Reported Exposure to Second-Hand Smoke and Positive Urinary Cotinine in Pregnant Nonsmokers
OB7 õ»óÈÆ ÇѾçÀÇ´ë Regression toward the mean in the fetal heart rate
OB8 ¿À°æÁØ ¼­¿ïÀÇ´ë Á¶±â¾ç¸·Æļö »ê¸ð¿¡¼­ ¾ç¼ö³» °¨¿°ÀÇ ¿øÀαտ¡ µû¸¥ ¾ç¼ö ¹× ¸ðü ¿°Áõ¹ÝÀÀÀÇ Â÷ÀÌ
ÁÂÀå : ÀüÁ¾°ü(¼­¿ïÀÇ´ë)
14:20~15:00 OB9 ¼Û½ÂÀº ¼º±Õ°üÀÇ´ë ½ÖÅÂÀӽſ¡¼­ À¶¸ð¸·¼º¿¡ µû¸¥ ÁÖ»ê±â ÀÌȯ·ü°ú »ç¸Á·ü
OB10 ±èÁ¤¸í ÀÌÈ­ÀÇ´ë ÀÚ°£ÀüÁõ°ú Àڱó» ¼ºÀåÁö¿¬À» º¸ÀÌ´Â ÀÓ»êºÎÀÇ Å¹ݿ¡¼­ÀÇ Endothelial nitric oxide synthase, Vascular endothelial growth factor, EndoglinÀÇ ¹ßÇö ºñ±³
OB11 À̹̹ü °üµ¿ÀÇ´ë Altered expression of anti-angiogenic factors (sFlt-1, sEng, and VEGF165b) in women who subsequently develop preeclampsia
OB12 ¼³ÇöÁÖ °æÈñÀÇ´ë Placental Catechol-O-methyltransferase expression in the patients with preeclampsia
ÁÂÀå : È«±â¿¬(¿ø±¤ÀÇ´ë)
15:00~15:40 OB13 À̼ø¾Ö °æ»óÀÇ´ë Antimicrobial Susceptibilities of Ureaplasma urealyticum and Mycoplasma hominis in Pregnant Women of Jinju, Korea
OB14 ±è¿¬Èñ °¡Å縯ÀÇ´ë Temporal gene expression during adipogenic differentiation of human chorion derived stem cells
OB15 Á¶±ÝÁØ °í·ÁÀÇ´ë D6 decoy receptor in missed abortion
OB16 ÀÌ°æÁø Â÷ÀÇ´ë ÁøÅë Áß Àΰ£Å¹ݿ¡¼­ À¯¹ßµÇ´Â À¯ÀüÀÚ ¹ßÇö º¯È­ÀÇ È®ÀÎÀ» À§ÇÑ mRNA oligonucleotide ¹Ì¼¼¹è¿­¹ýÀÇ ÀÌ¿ë
ÁÂÀå : ±è»çÁø(°¡Å縯ÀÇ´ë)
15:40~16:20 OB17 ÃÖ¼¼°æ °¡Å縯ÀÇ´ë Á¦´ëÇ÷ Base excess¿Í ÅÂ¾Æ »êÇ÷Áõ ¹× ½Å»ý¾Æ ¿¹ÈÄÀÇ »ó°ü°ü°è
OB18 ¼­Àº¼º ¼º±Õ°üÀÇ´ë ÀӽŠÀü ÀڱðæºÎ ¿øÃßÀýÁ¦¼úÀ» ½ÃÇà ¹ÞÀº ÀÓ»êºÎ¿¡¼­ Á¶»êÀ² ¹× ¿¹¹æÀû ÀڱðæºÎ ¿øÇü°áÂûÀÇ È¿°ú
OB19 ±èÇý¹Î À»ÁöÀÇ´ë ÀڱðæºÎ ¿ø»ÔÀýÁ¦¼úÀÌ Àӽſ¡ ¹ÌÄ¡´Â ¿µÇâ
OB20 Á¤È¿¿µ Á¶¼±ÀÇ´ë ÅÂ¾Æ ½ÉÃÊÀ½Æĸ¦ À§ÇØ »ïÂ÷ÀÇ·á±â°üÀ¸·Î Àü¿øµÇ´Â ȯÀÚµéÀÇ ÀûÀÀÁõ¿¡ ´ëÇÑ ºÐ¼®
ÁÂÀå : ¼ÕÀμ÷(°Ç±¹ÀÇ´ë)
16:20~17:00 OB21 ±è¼®¿µ °¡ÃµÀÇ´ë Assessment of a single value of hyperglycemia to predict the macrosomia in gestational diabetes mellitus(GDM)
OB22 ±èÁ¾¿î Àü³²ÀÇ´ë Àӽżº ´ç´¢¿Í Ä¡·á ÁßÀÎ Çö¼º´ç´¢ ÀӺο¡¼­ Ç×»ýÁ¦ ºÎÄ¡ ÈÄ Á¤¸ÆÇ÷Àå³» ÁöÁú°ú»êÈ­µµ¿Í ´Ü¹é»êÈ­µµÀÇ º¯È­
OB23 ¼Õ°¡Çö ¿¬¼¼ÀÇ´ë Effect of maternal insulin resistance on fetal growth in women with gestational diabetes mellitus (GDM)
OB24 ±è½ÅÇý °üµ¿ÀÇ´ë Association between First-and Second-Trimester Serum Screening Markers and Pregnancy Outcomes